Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models
Weijie Ma(Dartmouth–Hitchcock Medical Center), Tianhong Li(VA Northern California Health Care System)
Cited by 8
Related Papers
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416
Platelet–Leukocyte Hybrid Membrane‐Coated Immunomagnetic Beads for Highly Efficient and Highly Specific Isolation of Circulating Tumor Cells
|Advanced Functional Materials|2018|225
High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
|Journal of Hematology & Oncology|2019|51